Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
The American Society of Clinical Oncology annual meeting in Chicago last year. One of the conference’s coveted headliners this year will be a presentation of a clinical trial conducted only in China.
The disaster at the mill in Longview, Wash., which took at least eight lives, was greeted with sadness but not surprise by a community that knew cutbacks and other pressures had raised risks.
A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.
Ford Motor has written off $20 billion in electric vehicle investments but says it is forging ahead with an electric pickup that will sell for $30,000 next year.
The governments have no official diplomatic or military ties. But a loose network led by company executives and volunteers is bridging some of that gulf.
An industrial policy of subsidies and import restrictions laid the foundations for China to become almost as dominant in wind turbines as in solar panels.
Login
